Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 17/20 | 0.49 |
| ▸ | ITGAV | P06756 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31522342 | 0.84 | ITGB3 (0.51) | ITGB3ITGA2BITGAVNOD1 | |
| SCHEMBL6818957 | 0.84 | ITGB3 (0.51) | ITGB3ITGA2BITGAVNOD1 | |
| SCHEMBL8727473 | 0.81 | ITGB3 (0.51) | ITGB3ITGA2BITGAVNOD1CA2 | |
| SCHEMBL7395698 | 0.81 | ITGB3 (0.47) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| SCHEMBL8728096 | 0.81 | ITGB3 (0.51) | ITGB3ITGA2BITGAVNOD1CA2 | |
| SCHEMBL7144039 | 0.80 | ITGB3 (0.53) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| SCHEMBL7144029 | 0.80 | ITGB3 (0.53) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| SCHEMBL7118389 | 0.80 | ITGB3 (0.52) | ITGB3ITGA2BITGAVNOD1CA2 | |
| SCHEMBL4059094 | 0.78 | ITGB3 (0.51) | ITGB3ITGA2BITGAVNOD1 | |
| Trifluoroacetic Acid SCHEMBL7656989 | 0.78 | ITGB3 (0.49) | ITGB3ITGA2BITGAVCHRM2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004020402-A1 | SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | DE NOVO PHARMACEUTICALS LIMITED (GB) | 2004-03-11 | — | — | WO | claimed |
| WO-2004020402-A1 | SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | DE NOVO PHARMACEUTICALS LIMITED (GB) | 2004-03-11 | — | — | WO | disclosed |